Sphenopalatine Block

1

Review clinical trials related to Sphenopalatine Block. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine

This trial compares the efficacy and safety of sphenopalatine ganglion block (SPGB) and intramuscular BOTOX injection in chronic migraine.

Participants needed: 64
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Cairo UniversityUpdated: May 16, 2025Locations: 1
Eligibility criteria

Age 18 and 65 years. [+2]

Patients with medication over use headache. [+3]